In the News

For media inquiries, please contact innovations@ccf.org

05/05/2022

XII Medical Completes $30 Million Series A Financing

Cleveland Clinic start-up XII Medical completed a $30 million round of financing. 


02/16/2022

Cleveland Clinic Unveils Top 10 Medical Innovations for 2022

Next generation mRNA vaccines. A new PSMA-targeted approach for prostate cancer. A novel treatment for reducing LDL cholesterol. These are some of the innovations that will optimize and change healthcare in the coming year, according to an expert panel of clinicians and researchers. Cleveland Clinic has announced the Top 10 Medical Innovations for 2022. The list of breakthrough technologies was selected by a committee of Cleveland Clinic subject matter experts, led by D. Geoffrey Vince, Ph.D., executive director of Innovations and chair of Biomedical Engineering at Cleveland Clinic.


01/19/2022

Launch of Cleveland Clinic Brain Study Marks Unprecedented Effort to Disrupt Neurological Diseases

Cleveland Clinic has launched a landmark study to better understand the mechanisms of neurological diseases, with the goal of pinpointing disease biomarkers early, well before clinical symptoms manifest. The new Cleveland Clinic Brain Study — the largest clinical study ever for brain disease — will prospectively collect data from up to 200,000 neurologically healthy individuals over a 20-year period to identify brain disease biomarkers and targets for preventing and curing neurological disorders.


11/18/2021

5 Innovations That Are Changing the Delivery of Care

Experts at Cleveland Clinic have invested in research and technology designed to improve outcomes and the patient experience. From diagnosis and biopsy to surgical approaches and longer-term management—learn more about how the team is leading the way in prostate cancer.


11/02/2021

First U.S. Patient Enrolled in Cardionomic's CPNS Pilot Study

Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce initial U.S. enrollment in their global Cardiac Pulmonary Nerve Stimulation (CPNS) Pilot Study (NCT04814134). The study is evaluating the safety and performance of the CPNS System in patients suffering from acute decompensated heart failure (ADHF), defined as new or worsening symptoms of heart failure. The first U.S. patient was enrolled and implanted at The Ohio State University Wexner Medical Center in Columbus, OH by Principal Investigator, Dr. Sitaramesh Emani, assisted by Dr. Rami Kahwash


10/26/2021

Cleveland Clinic Launches First-of-its-Kind Preventative Breast Cancer Vaccine Study

Cleveland Clinic has begun clinical testing of a novel vaccine designed ultimately to prevent triple-negative breast cancer (TNBC) by priming high-risk women to mount an immune response against a “retired” lactation protein expressed only in cancer cells


10/19/2021

Cleveland Clinic Surgical Team Performs First Right-Sided Robotic Liver Resection

Traditional liver surgery is performed through one open incision incision below the ribs or along the midline and takes a significant amount of recovery. Over the past 10 years, minimally invasive liver resection has emerged as a viable alternative. This robotic-assisted right-sided hepatectomy was the first one performed at Cleveland Clinic.


10/11/2021

Opening of Cleveland Clinic BioRepository Expands Infrastructure for Pursuit of Personalized Medicine

Cleveland Clinic and Brooks Automation have opened the Cleveland Clinic BioRepository to increase the storage capacity for biological samples at Cleveland Clinic while enhancing researchers’ study of human tissue samples to more rapidly translate laboratory discoveries into new treatments for patients.


09/14/2021

Cleveland Diagnostics Presents New Data Supporting the Clinical Validation and Clinical Utility of ISoPSA

Cleveland Diagnostics, Inc., a commercial stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, announced today that Eric Klein, MD, Chairman of the Glickman Urological & Kidney Institute at Cleveland Clinic, delivered two presentations at the annual meeting of the American Urological Association regarding the company’s prostate cancer test, IsoPSA


09/07/2021

Bionic Arm's Neurorobotic Sensory-Motor Fusion Restores Natural Behaviors

In a new study published in Science Robotics, a Cleveland Clinic-led research team reports that it has engineered a first-of-its-kind neurorobotic prosthetic arm for patients with upper-limb amputations that allows wearers to think, behave and function more like a person without an amputation.


   < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >   

Get In Touch With Us